Skip to main content
Fig. 2 | Cancer Imaging

Fig. 2

From: Development and validation of a nomogram model based on pretreatment ultrasound and contrast-enhanced ultrasound to predict the efficacy of neoadjuvant chemotherapy in patients with borderline resectable or locally advanced pancreatic cancer

Fig. 2

A Nomogram for predicting tumor response (To use the nomogram, an individual patient’s value is located on each variable axis, and a line is drawn upward to determine the number of points received for each variable value. The sum of these numbers is located on the total points axis, and a line is drawn downward to the risk axes to determine the probability of being “responders”) B ROC of the nomogram in the training and validation cohort C Calibration curve of the nomogram in the training cohort D Decision curve analysis for the nomogram. The y-axis measures the net benefit, x-axis indicates threshold probability. The red line represents the net benefit of the predictive nomogram

Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us